Regulatory & Safety
Internet Live Events
Mergers and acquisitions
APIs (active pharmaceutical ingredients)
Excipients, raw materials and intermediates
Packaging machinery & supplies
Tabletting, coating & ancillary equipment
Videos & Audio
Shows & Conferences
CPhI Worldwide Paris 2014
AAPS 2014 San Diego
TechnoPharm / POWTECH 2014 Nuremberg, Germany
AAPS 2013 in San Antonio
CPhI 2013 in Frankfurt
Interphex 2013 in New York
AAPS 2012 in Chicago
CPhI 2012 in Madrid
Achema 2012 in Frankfurt
Interphex 2012 in New York
Interphex 2011 in New York
AAPS 2010 in New Orleans
Counterfeiting is a priority across the phamaceutical supply chain. Serialization and Pedigree requirements and solutions are still evolving. I would like to see participation in these types of projects by Manufacturers, Distributors, Retailers and Consumers. Also, the many standards determining bodies, i.e, GS1, HDMA, etc. should be connected to the effort. There needs to be a holistic approach that ties together the many requirements and regulations into one universal solution with defined standards. Many supply chain partners are looking to 2015 and the California mandate. This effort should be synergistic with state and federal regulations.
Posted by Bill Ricigliano14 October 2010 | 14h31
Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.
We will not publish your email on the site
Back to: FDA & WHO collaborate on surveillance of counterfeit drugs
Access all events listing
Our events, Shows & Conferences...
Subscribe to our FREE newsletterSUBSCRIBE
Contract Research, Manufacturing & Clinical Trials
Biopharmaceutical Development & Manufacturing
About us | Site map |
© William Reed Business Media SAS 2015, All rights reserved.